Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90

被引:160
作者
Ge, Jie [1 ]
Normant, Emmanuel [1 ]
Porter, James R. [1 ]
Ali, Janid A. [1 ]
Dembski, Marlene S. [1 ]
Gao, Yun [1 ]
Georges, Asimina T. [1 ]
Grenier, Louis [1 ]
Pak, Roger H. [1 ]
Patterson, Jon [1 ]
Sydor, Jens R. [1 ]
Tibbitts, Thomas T. [1 ]
Tong, Jeffrey K. [1 ]
Adams, Julian [1 ]
Palombella, Vito J. [1 ]
机构
[1] Infin Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
HEAT-SHOCK-PROTEIN; N-TERMINAL DOMAIN; MOLECULAR CHAPERONE; GELDANAMYCIN DERIVATIVES; CRYSTAL-STRUCTURE; GROWTH ARREST; HEAT-SHOCK-PROTEIN-90; CANCER; EXPRESSION; DEGRADATION;
D O I
10.1021/jm0603116
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
17-Allylamino-17-demethoxygeldanamycin (17-AAG)(1) is a semisynthetic inhibitor of the 90 kDa heat shock protein (Hsp90) currently in clinical trials for the treatment of cancer. However, 17-AAG faces challenging formulation issues due to its poor solubility. Here we report the synthesis and evaluation of a highly soluble hydroquinone hydrochloride derivative of 17-AAG, 1a (IPI-504), and several of the physiological metabolites. These compounds show comparable binding affinity to human Hsp90 and its endoplasmic reticulum (ER) homologue, the 94 kDa glucose regulated protein (Grp94). Furthermore, the compounds inhibit the growth of the human cancer cell lines SKBR3 and SKOV3, which overexpress Hsp90 client protein Her2, and cause down-regulation of Her2 as well as induction of Hsp70 consistent with Hsp90 inhibition. There is a clear correlation between the measured binding affinity of the compounds and their cellular activities. Upon the basis of its potent activity against Hsp90 and a significant improvement in solubility, 1a is currently under evaluation in Phase I clinical trials for cancer.
引用
收藏
页码:4606 / 4615
页数:10
相关论文
共 66 条
[61]  
Wegele H., 2004, REV PHYSL BIOCH PHAR
[62]   Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo [J].
Whitesell, L ;
Sutphin, P ;
An, WG ;
Schulte, T ;
Blagosklonny, MV ;
Neckers, L .
ONCOGENE, 1997, 14 (23) :2809-2816
[63]   INHIBITION OF HEAT-SHOCK PROTEIN HSP90-PP60(V-SRC) HETEROPROTEIN COMPLEX-FORMATION BY BENZOQUINONE ANSAMYCINS - ESSENTIAL ROLE FOR STRESS PROTEINS IN ONCOGENIC TRANSFORMATION [J].
WHITESELL, L ;
MIMNAUGH, EG ;
DECOSTA, B ;
MYERS, CE ;
NECKERS, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8324-8328
[64]   Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone [J].
Workman, P .
CANCER LETTERS, 2004, 206 (02) :149-157
[65]   HIGH CONSTITUTIVE EXPRESSION OF HEAT-SHOCK PROTEIN 90-ALPHA IN HUMAN ACUTE-LEUKEMIA CELLS [J].
YUFU, Y ;
NISHIMURA, J ;
NAWATA, H .
LEUKEMIA RESEARCH, 1992, 16 (6-7) :597-605
[66]  
ZHANG L, 2003, Patent No. 030267571